Echoviruses have been implicated in multiple human disease syndromes, including aseptic meningitis, paralysis, and heart disease, but no animal model is available for studying the pathogenesis of infection. Production of human integrin very late antigen 2, a receptor for echovirus type 1, in transgenic mice conferred susceptibility to viral infection. Intracerebral inoculation of newborn transgenic mice with echovirus leads to paralysis and wasting. No disease was observed in infected nontransgenic mice. In paralyzed mice significant damage was observed in the outer layers of the cerebrum, and numerous condensed neuronal nuclei were present. In contrast, intracerebral inoculation of adolescent (3-to 4-weekold) transgenic mice with echovirus type 1 did not lead to paralysis but an acute wasting phenotype and myocarditis. These findings establish human very late antigen 2 transgenic mice as a model for echovirus pathogenesis. E choviruses, like polioviruses and coxsackieviruses, are nonenveloped RNA viruses that are members of the Enterovirus group of the family Picornaviridae. It is estimated that 10-15 million illnesses are caused each year by nonpolio enteroviruses in the United States (1). Although the vast majority of these illnesses are not serious, a wide range of potentially fatal human diseases, including aseptic meningitis, encephalitis, paralysis, type I diabetes mellitus, and myocarditis, have been associated with echovirus infections (2).Members of the enteric cytopathogenic human orphan group of viruses (echoviruses) were initially distinguished from coxsackieviruses by their inability to replicate and cause disease in newborn mice (3). Because a small animal model is not available, much of what is known about echovirus pathogenesis is inferred from epidemiological surveillance studies and mouse models for coxsackievirus and poliovirus pathogenesis. As is the case for poliovirus, the cellular receptor is most likely a major determinant of the restricted host range of echoviruses (4-7). A receptor molecule that is both sufficient and necessary to mediate virus binding and entry has been identified for only 1 of the 31 echovirus serotypes, echovirus type 1 (EV1) (8). A cellular receptor for EV1 is human very late antigen 2 (VLA-2), a heterodimer comprising one ␣2 subunit and one 1 subunit (integrin ␣2͞1). EV1 interacts with the collagen binding I domain of human ␣2 integrin subunits (9). Although EV1 binding and entry are mediated solely by the ␣2 subunit, association of an ␣2 subunit with a 1 subunit is required for proper transport of ␣2͞1 integrin to the cell surface (10). Production of the ␣2 polypeptide in rodent cells is sufficient to render these cells susceptible to infection by EV1, indicating that human-␣2͞mouse-1 heterodimers can serve as functional EV1 receptors (8, 11). Widespread cell and tissue synthesis of integrin ␣2͞1 is consistent with the hypothesis that many target organs are involved in EV1 pathogenesis (12).Transgenic mice that produce human cell receptors for infectious ag...